EP2747734A1 - High recovery vial adaptor - Google Patents
High recovery vial adaptorInfo
- Publication number
- EP2747734A1 EP2747734A1 EP12753345.3A EP12753345A EP2747734A1 EP 2747734 A1 EP2747734 A1 EP 2747734A1 EP 12753345 A EP12753345 A EP 12753345A EP 2747734 A1 EP2747734 A1 EP 2747734A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- component
- passage
- angle
- seal
- flexible tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011084 recovery Methods 0.000 title claims description 8
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 27
- 239000007788 liquid Substances 0.000 abstract description 14
- 108030001720 Bontoxilysin Proteins 0.000 abstract description 3
- 229940053031 botulinum toxin Drugs 0.000 abstract description 3
- 239000011521 glass Substances 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- -1 polytetrafluoroethylene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/065—Rigid ampoules, e.g. glass ampoules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
Definitions
- Many medicaments for example, botulinum toxin, are sold in small glass vials with a cap that comprises a seal.
- the seal is puncturable to allow liquid to be added, for example, to reconstitute the medicament.
- the reconstituted medicament may then be withdrawn through a needle into a syringe.
- One disadvantage of this type of packaging may be that the needle and syringe configuration may not be able to draw a significant amount of the liquid in the vial, thus resulting in loss of a significant part of the product. This is especially undesirable when the medicament is expensive.
- an adaptor device for facilitating efficient recovery of fluid from a vial.
- the device allows a substantially larger, or at least more significant, amount of a liquid medicament to be withdrawn from a vial.
- the device includes a puncture component that allows a flexible tube to be inserted through the seal at an angle that allows an end of a flexible tube to rest on the bottom on a vial around the edge of the vial. This may allow vial to be tipped so that the liquid pools around the end of the flexible tube, thus significantly increasing the amount of liquid that can be withdrawn for use.
- an adaptor device in accordance with one embodiment comprises: a puncture component, a flexible tube, an inserter, and a coupling component.
- a puncture component may have a cylindrical portion, a proximal end, and a tapered distal end configured to puncture a seal.
- the puncture component may have a passage comprising: an entrance at or near the proximal end of the puncture component; a interior portion, connected to the entrance, and residing entirely within the puncture component; and an exit, connected to the interior portion so that the interior portion is between the first portion and the exit.
- a puncture component may be configured to allow the entrance of the passage and the exit of the passage to be on opposite sides of the seal.
- An inserter may be coupled to the flexible tube and configured to direct the distal end of the tube through the passage and out of the exit of the passage.
- a coupling component may be configured to allow fluid communication between the proximal end of the flexible tube and a syringe.
- the puncture component is configured to allow the entrance of the passage and the exit of the passage to be on opposite sides of the seal.
- the device is configured to allow the flexible tube to be guided through the seal via the puncture component so that the distal end of the flexible tube extends from the exit of the puncture component at an angle that is not perpendicular to the seal.
- a method of recovering a medicament, such as a botulinum toxin, from a vial including the steps of drawing a medicament from the vial using an adaptor device as described herein.
- Figure 1A is a perspective view of a high recovery adaptor device, in accordance with an embodiment of the invention, being used with a medicament vial having a puncturable seal;
- Figure 1 B is another perspective view of the device shown in Figure 1 , with a recovery tube being inserted therein;
- Figure 1 C is a cross-sectional view of an angled passageway feature of the device
- Figure 2 is a perspective view of a device, in accordance with an embodiment of the invention, as coupled to a medicament vial;
- Figure 3 and 3A are cross-sectional views of the device shown in Figure 2;
- Figure 4 is another cross-sectional view of the device shown in Figure 2, with a recovery tube inserted therein;
- Figure 5 is a perspective view of another device in accordance with an embodiment of the invention.
- Figure 6 and 7 are cross-sectional views of the device shown in Figure 5;
- Figure 8 is a perspective view of yet another device in accordance with an embodiment of the invention.
- Figure 9 and 10 are cross-sectional views of the device shown in Figure 8.
- Figures 1 1 and 12 are cross-sectional views of a coupling component feature of certain embodiments of the invention.
- an adaptor device in accordance with the invention, may comprise a puncture component, a flexible tube, an inserter, and a coupling component. While there are many ways the present adaptor may be configured, schematic drawing of some embodiments are shown.
- FIGS 1 A and 1 B show an adaptor device 8 comprising a puncture component 10, the puncture component 10 being shown penetrating a medicament vial seal 50.
- the adaptor device 8 may include a flexible conduit or tube 100.
- the flexible tube 100 has a distal end 1 10 and a proximal end 102. Tube 100 is shown in a retracted state in Figure 1A and is shown in an extended state in Figure 1 B.
- Puncture component 10 comprise a body 20, for example, a cylindrical body 20, having a proximal end 30, and a tapered distal end 40.
- Distal end 40 is configured to puncture a seal 50, for example, an existing seal 50 on a medicament container.
- a seal is typically configured to be punctured by a needle or cannula for reconstituting medicament and/ or for withdrawal of medicament through a needle into a syringe.
- Seal 50 may be a polymer such as a latex or rubber, polytetrafluoroethylene, a polyalkylene, an acrylic, a polyurethane, a polyalkylene, a substituted vinyl polymer, etc.; a foil such as an aluminum foil; paper; cork; etc.
- the puncture component 10 includes a passage 60 configured to receiving tube 100.
- Passage 60 includes an inlet or entrance 70 at or near the proximal end 30 of the puncture component 10.
- Passage 60 may be defined by interior wall portion 80, connected to the entrance 70, and residing within the puncture component 10.
- Passage 60 also includes an exit 90 at the distal end of the interior portion 80.
- entrance 70 of the passage 60 and the exit 90 of the passage 60 are generally disposed on opposing sides of the seal 50.
- Passage 60 may include an angle such as shown in FIGS. 1A and 1 B, such that proximal portion 62 of passage 60 is disposed substantially perpendicular to seal 50, and distal portion 64 of passage 60 is disposed at an angle with respect to proximal portion 62.
- passage 60 may be substantially entirely linear, without an angle between distal portion and proximal portion, such as depicted in FIG. 1 C.
- passage 60 shown in Figure 1 C would be disposed at an angle other than perpendicular to seal 50.
- seal 50 itself may not be part of a device or a method described herein.
- Tube 100 and passage 60 are generally sized and structured to allow tube 100 to be easily inserted and passed through the full length of passage 60.
- passage 60 has an inner diameter of about 0.1 mm to about 2 mm
- tube 100 has an outer diameter of about 0.05 mm to about 1 .5 mm.
- the puncture component 10 is configured so that when a flexible tube 100 is extended through the passage 60 of the puncture component 10, the distal portion of the flexible tube 100, e.g. the portion of flexible tube 100 between the exit 90 of the passage 60 and the distal end 1 10 of flexible tube 100, may form an angle that is not perpendicular to the seal 50.
- Angle of tube 100 guided by passage 60 is sized to direct distal end of tube 100 to a corner of the vial, for example, to enhance recovery of liquid medicament therefrom.
- flexible tube 100 When the device 8 is in use for recovering medicament, flexible tube 100 is extended distally through passage 60 such that the distal end 1 10 of tube 100 may rest on or near the bottom of a vial containing liquid medicament, for example, away from a center of the vial.
- the vial When the liquid level is low, the vial can be tipped so that the liquid pools around the tube distal end 1 10.
- a significantly greater amount of medicament can be withdrawn for use as compared to withdrawal by a needle in a conventional manner.
- device 210 is configured to direct a distal end of tube 100 in a direction not perpendicular with the a plane defined by seal 50, when device is placed on or coupled to seal 50.
- passage 60 may be configured to direct tube at an angle not perpendicular to seal 50.
- angle 135, defined as the angle between longitudinal axis of proximal portion of passage 60 and longitudinal axis of distal portion of passage 60 may be an angle of greater than 0° to less than 90°.
- angle 135 may be about 10° to about 80°, about 20° to about 70°, for example, about 30° to about 60° degrees, for example, about 40° to about 50 °degrees.
- tube 100 when the adapter is in use and placed in or engaged with a seal of a vial, tube 100 generally is aligned at an angle about 40° to about 80°, about 60° to about 75°, or about 65° to about 70° from a plane defined by seal 50.
- tube 100 is sufficiently flexible to pass through bend 132 in passage 60, for example, without kinking or collapsing.
- An inserter 200 may be coupled to the flexible tube 100.
- An inserter 200 may be any feature configured to direct the distal end 1 10 of the tube 100 through the passage 60, so that part of flexible tube 100 extends beyond the exit 90 of passage 60.
- Some inserters may be similar to an inserter 200 depicted in FIGS. 2-4, discussed below.
- Inserter 200 may comprise a fixed component 510 which is affixed to puncture component 10.
- the fixed component 510 may be an open cylinder having a platform 515 affixed toward the bottom 525 of the fixed component 510. Puncture component 10 is affixed to the platform 515 so that it extends beyond the bottom 525 of the fixed component 510.
- a cap 600 of a medicament bottle 650 may meet platform 515 so that puncture component 10 pierces seal 50 of cap 600.
- a movable component 520 is moveably coupled to the fixed component 510.
- Movable component 520 may be an open cylinder which slidably engages open cylinder of the fixed component 510.
- Moveable component 510 may comprise a ceiling 560.
- Ceiling 560 may be affixed to a descending guiding cylinder 540.
- An ascending guiding cylinder 530 may extend upward from platform 515 to guide the moveable component 520 into the fixed component 510, as shown in FIGS. 3 and 4.
- FIG. 4 Moveable component 520 is slid into fixed component 510 to a collapsed configuration, shown in FIG. 4.
- flexible tube 100 is withdrawn from puncture component 10 such that distal end 1 10 of flexible tube 100 does not protrude past exit 90 of passage 60.
- a collapsed configuration (figure 4)
- flexible tube 100 is extended past exit 90 of passage 60, for example, such that distal end 1 10 of tube 100 contacts vial corner.
- Other inserters 200 of the invention may be configured as depicted in FIGS. 5-7.
- inserter 200 comprises fixed component 320 which is affixed to puncture component 10.
- Fixed component 320 may be an open cylinder having a platform 330. Puncture component 10 is affixed to platform 330 so that it extends beyond the bottom 340.
- a cap 600 of a medicament bottle 650 may meet platform 330 so that puncture component 10 pierces seal 50 of cap 600.
- Rotatable component 350 may be configured to fit inside fixed component 320 and rotate with respect to fixed component 320.
- Rotatable component 350 may comprise a spool component 355 which is rotatably coupled to fixed component 320.
- Spool component 355 may further comprise rotatable male fitting 360 that couples to fixed female fitting 390 that may be part of platform 330.
- Flexible tube 100 may be wrapped around spool component 355 so that rotation of rotatable component 350 inserts tube 100 through passage 60.
- Inserter 200 may comprise fixed component 720 which is affixed to puncture component 10.
- Fixed component 720 may be an open cylinder having platform 730. Puncture component 10 is affixed to platform 730 so that it extends beyond the bottom 740 of fixed component 720.
- a cap 600 of a medicament bottle 650 may meet platform 720 so that puncture component 10 pierces seal 50 of cap 600.
- Rotatable component 800 may be configured to fit inside fixed component 720 and rotate with respect to fixed component 720.
- Rotatable component 800 may comprise a spool component 810 which is rotatably coupled to fixed component 720.
- Spool component 810 may further comprise rotatable spool fittings 830 and 840 that couple to fixed fittings 750 and 760 that may be part of platform 730.
- Flexible tube 100 may be wrapped or wound around spool component 810 so that rotation of rotatable component 800 effects distal movement and insertion of tube 100 through passage 60.
- the inserter includes a suitable locking mechanism to prevent retraction of the tube during insertion.
- the coupling component 300 may be any structural feature configured to allow fluid communication between the proximal end 102 of the flexible tube and a means for withdrawing fluid therefrom, for example, a syringe.
- Exemplary coupling components 300 may be configured, for example, as depicted in FIGS. 1 1 -12.
- the coupling component 300 may comprise a reservoir component 905 in fluid communication with the proximal end 102 of the flexible tube 100.
- a valve 550 may be coupled to the reservoir component 905.
- a syringe component 910 may be configured so that valve 550 is opened when the syringe component 910 is coupled to the reservoir component 905.
- Syringe component 910 comprises stopper 960.
- a gap 945 may allow flow of fluid medicament to a syringe.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161526649P | 2011-08-23 | 2011-08-23 | |
| PCT/US2012/051880 WO2013028767A1 (en) | 2011-08-23 | 2012-08-22 | High recovery vial adaptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2747734A1 true EP2747734A1 (en) | 2014-07-02 |
| EP2747734B1 EP2747734B1 (en) | 2016-06-22 |
Family
ID=46759103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12753345.3A Not-in-force EP2747734B1 (en) | 2011-08-23 | 2012-08-22 | High recovery vial adaptor |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20130053815A1 (en) |
| EP (1) | EP2747734B1 (en) |
| AU (1) | AU2012298918A1 (en) |
| CA (1) | CA2846435A1 (en) |
| ES (1) | ES2590492T3 (en) |
| WO (1) | WO2013028767A1 (en) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6695817B1 (en) | 2000-07-11 | 2004-02-24 | Icu Medical, Inc. | Medical valve with positive flow characteristics |
| US20060161115A1 (en) | 2004-11-05 | 2006-07-20 | Fangrow Thomas F | Soft-grip medical connector |
| US7547300B2 (en) | 2006-04-12 | 2009-06-16 | Icu Medical, Inc. | Vial adaptor for regulating pressure |
| WO2010022095A1 (en) | 2008-08-20 | 2010-02-25 | Icu Medical, Inc. | Anti-reflux vial adaptors |
| US9168366B2 (en) | 2008-12-19 | 2015-10-27 | Icu Medical, Inc. | Medical connector with closeable luer connector |
| US8454579B2 (en) | 2009-03-25 | 2013-06-04 | Icu Medical, Inc. | Medical connector with automatic valves and volume regulator |
| AU2010276522B2 (en) | 2009-07-29 | 2016-03-10 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
| US8323249B2 (en) | 2009-08-14 | 2012-12-04 | The Regents Of The University Of Michigan | Integrated vascular delivery system |
| USD644731S1 (en) | 2010-03-23 | 2011-09-06 | Icu Medical, Inc. | Medical connector |
| US8758306B2 (en) | 2010-05-17 | 2014-06-24 | Icu Medical, Inc. | Medical connectors and methods of use |
| WO2011146769A2 (en) | 2010-05-19 | 2011-11-24 | Tangent Medical Technologies Llc | Integrated vascular delivery system |
| US8814833B2 (en) | 2010-05-19 | 2014-08-26 | Tangent Medical Technologies Llc | Safety needle system operable with a medical device |
| EP2959880B1 (en) * | 2010-05-27 | 2017-04-12 | J&J Solutions, Inc. | Closed fluid transfer system |
| WO2013025946A1 (en) | 2011-08-18 | 2013-02-21 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| US20130053815A1 (en) * | 2011-08-23 | 2013-02-28 | Allergan, Inc. | High recovery vial adaptor |
| AU2012304344B2 (en) | 2011-09-09 | 2016-02-04 | Icu Medical, Inc. | Medical connectors with fluid-resistant mating interfaces |
| AU2012324021A1 (en) | 2011-12-22 | 2013-07-11 | Icu Medical, Inc. | Fluid transfer devices and methods of use |
| CN104168948B (en) | 2012-01-13 | 2017-03-01 | Icu医学有限公司 | Controlled pressure type phial joint and method |
| WO2013142618A1 (en) | 2012-03-22 | 2013-09-26 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| AU2013342123B2 (en) | 2012-11-12 | 2018-08-02 | Icu Medical, Inc. | Medical connector |
| US9089475B2 (en) | 2013-01-23 | 2015-07-28 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| AU2014209594B2 (en) | 2013-01-23 | 2018-09-13 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| CN105163796B (en) | 2013-03-15 | 2018-06-01 | Icu医学有限公司 | Medical connector |
| AU2014290124B2 (en) | 2013-07-19 | 2019-05-09 | Icu Medical, Inc. | Pressure-regulating fluid transfer systems and methods |
| WO2015066335A1 (en) * | 2013-10-30 | 2015-05-07 | NorthStar Medical Radioisotopes LLC | Parent radionuclide container |
| AU2014353184B2 (en) | 2013-11-25 | 2017-08-17 | Icu Medical, Inc. | Methods and system for filling IV bags with therapeutic fluid |
| EP3079739B1 (en) | 2013-12-11 | 2023-02-22 | ICU Medical, Inc. | Check valve |
| JP6461174B2 (en) | 2014-02-04 | 2019-01-30 | アイシーユー・メディカル・インコーポレーテッド | Self-priming system and self-priming method |
| CA2953229C (en) | 2014-06-20 | 2024-01-02 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| USD786427S1 (en) | 2014-12-03 | 2017-05-09 | Icu Medical, Inc. | Fluid manifold |
| USD793551S1 (en) | 2014-12-03 | 2017-08-01 | Icu Medical, Inc. | Fluid manifold |
| US9527639B2 (en) * | 2015-01-26 | 2016-12-27 | Cardomon International Limited | Dip tube insertion member for facilitating insertion of a dip tube into a container without removing the container cap |
| US9714164B2 (en) | 2015-05-18 | 2017-07-25 | Cardomon International Limited | Apparatus for storing and dispensing liquid from a liquid retaining bag |
| WO2017096072A1 (en) | 2015-12-04 | 2017-06-08 | Icu Medical, Inc. | Systems methods and components for transferring medical fluids |
| CA3012733C (en) | 2016-01-29 | 2023-09-12 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| USD851745S1 (en) | 2016-07-19 | 2019-06-18 | Icu Medical, Inc. | Medical fluid transfer system |
| EP3487468B1 (en) | 2016-07-25 | 2025-10-01 | ICU Medical, Inc. | Systems and components for trapping air bubbles in medical fluid transfer modules and systems |
| JP7063891B2 (en) | 2016-09-30 | 2022-05-09 | アイシーユー・メディカル・インコーポレーテッド | Vial adapter |
| WO2020180507A1 (en) | 2019-03-01 | 2020-09-10 | Skin NY Dermatology, PLLC | Vial adapter for drawing drugs from a vial |
| US11590057B2 (en) | 2020-04-03 | 2023-02-28 | Icu Medical, Inc. | Systems, methods, and components for transferring medical fluids |
| IL316431A (en) * | 2022-04-22 | 2024-12-01 | Norton Healthcare Ltd | Vial adapter and vial adapter system and method |
| USD1105422S1 (en) | 2024-02-09 | 2025-12-09 | Icu Medical, Inc. | Medical connector cover |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1189465A (en) * | 1916-01-24 | 1916-07-04 | Abbott Lab | Container for hypodermic solutions. |
| US2415871A (en) * | 1944-12-07 | 1947-02-18 | Ace Glass Inc | Container for aseptic filling and dispensing of sterile liquids |
| US3608550A (en) * | 1969-05-07 | 1971-09-28 | Becton Dickinson Co | Transfer needle assembly |
| US4505709A (en) * | 1983-02-22 | 1985-03-19 | Froning Edward C | Liquid transfer device |
| US4808381A (en) * | 1983-05-13 | 1989-02-28 | E. I. Du Pont De Nemours And Company | Fluid transfer device |
| US5100394A (en) * | 1988-01-25 | 1992-03-31 | Baxter International Inc. | Pre-slit injection site |
| US5429803A (en) * | 1991-04-18 | 1995-07-04 | Lamina, Inc. | Liquid specimen container and attachable testing modules |
| US5301560A (en) * | 1991-11-22 | 1994-04-12 | Texas Sampling, Inc. | Closed loop liquid sampler and sampling system |
| US5433343A (en) * | 1993-07-30 | 1995-07-18 | Meshberg; Philip | Delivery system for measured quantities of liquids, especially medications |
| US5364387A (en) * | 1993-08-02 | 1994-11-15 | Becton, Dickinson And Company | Drug access assembly for vials and ampules |
| EP0692235A1 (en) * | 1994-07-14 | 1996-01-17 | International Medication Systems (U.K.) Ltd. | Mixing & dispensing apparatus |
| US5512547A (en) * | 1994-10-13 | 1996-04-30 | Wisconsin Alumni Research Foundation | Pharmaceutical composition of botulinum neurotoxin and method of preparation |
| EP0839255B1 (en) * | 1995-07-25 | 2003-09-10 | Nowsco Well Service, Inc. | Safeguarded method and apparatus for fluid communication using coiled tubing, with application to drill stem testing |
| GB2314322A (en) * | 1996-06-21 | 1997-12-24 | Merck & Co Inc | Deflected septum seal access port |
| US6003566A (en) * | 1998-02-26 | 1999-12-21 | Becton Dickinson And Company | Vial transferset and method |
| US6475183B1 (en) * | 1998-06-03 | 2002-11-05 | Baxter International Inc. | Direct dual filling device for sealing agents |
| US6832994B2 (en) * | 2000-01-24 | 2004-12-21 | Bracco Diagnostics Inc. | Table top drug dispensing vial access adapter |
| US7799009B2 (en) * | 2000-01-24 | 2010-09-21 | Bracco Diagnostics Inc. | Tabletop drug dispensing vial access adapter |
| US6544246B1 (en) * | 2000-01-24 | 2003-04-08 | Bracco Diagnostics, Inc. | Vial access adapter and vial combination |
| US7243689B2 (en) * | 2000-02-11 | 2007-07-17 | Medical Instill Technologies, Inc. | Device with needle penetrable and laser resealable portion and related method |
| US6269976B1 (en) * | 2000-08-17 | 2001-08-07 | Saint-Gobain Calmar Inc. | Vial access spike adapter for pump sprayer |
| DE60218296T2 (en) * | 2001-03-27 | 2007-07-12 | Eli Lilly And Co., Indianapolis | KIT WITH A SYRINGE PAD WITH SIDE OPENING FOR PREPARING A MEDICAMENT IN AN INJECTION PEN CARTRIDGE |
| WO2004000678A1 (en) * | 2002-06-25 | 2003-12-31 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Mixing vial |
| ATE534325T1 (en) * | 2005-06-24 | 2011-12-15 | Ge Inspection Technologies Lp | INTRODUCTION TUBE STORAGE CAROUSEL |
| CN104162200B (en) * | 2006-02-09 | 2018-03-27 | 德卡产品有限公司 | peripheral system |
| US7984832B2 (en) * | 2006-10-23 | 2011-07-26 | The Clorox Company | Pump dispenser for use with substrates |
| US7871217B2 (en) * | 2006-12-12 | 2011-01-18 | The Clorox Company | Pump systems for pump dispensers |
| US7980777B2 (en) * | 2007-01-09 | 2011-07-19 | The Clorox Company | Fluid dispensing system with separate pump actuator and dispensing pad |
| US8226619B2 (en) * | 2007-06-15 | 2012-07-24 | Kyphon Sarl | Systems and methods for needle access to an intervertebral disc |
| FR2928539B1 (en) * | 2008-03-12 | 2012-02-24 | Vygon | INTERFACING DEVICE FOR PERFORATING BOTTLES FOR THE PREPARATION OF PERFUME FLUIDS |
| US20100102094A1 (en) * | 2008-10-28 | 2010-04-29 | Berry Plastics Corporation | Package with fluid-dispenser system |
| EP2387473B1 (en) * | 2009-01-16 | 2013-11-06 | Colgate-Palmolive Company | Dispensing container comprising a pump receiving fitment |
| IL201323A0 (en) * | 2009-10-01 | 2010-05-31 | Medimop Medical Projects Ltd | Fluid transfer device for assembling a vial with pre-attached female connector |
| EP2624801A1 (en) * | 2010-10-06 | 2013-08-14 | Allergan, Inc. | System for storage and subsequent handling of botulinum toxin |
| US8721612B2 (en) * | 2010-12-17 | 2014-05-13 | Hospira, Inc. | System and method for intermixing the contents of two containers |
| US20130053815A1 (en) * | 2011-08-23 | 2013-02-28 | Allergan, Inc. | High recovery vial adaptor |
| US8945087B2 (en) * | 2011-09-30 | 2015-02-03 | Covidien Lp | Pre-pierced IV access port |
| IL215699A0 (en) * | 2011-10-11 | 2011-12-29 | Medimop Medical Projects Ltd | Liquid drug reconstitution assemblage for use with iv bag and drug vial |
| US20140005597A1 (en) * | 2012-05-01 | 2014-01-02 | Compassion Physicians Associates, P.C. | Kit and method for use in administering therapeutic botulinum toxin (botox) |
-
2012
- 2012-08-21 US US13/590,838 patent/US20130053815A1/en not_active Abandoned
- 2012-08-22 ES ES12753345.3T patent/ES2590492T3/en active Active
- 2012-08-22 WO PCT/US2012/051880 patent/WO2013028767A1/en not_active Ceased
- 2012-08-22 EP EP12753345.3A patent/EP2747734B1/en not_active Not-in-force
- 2012-08-22 AU AU2012298918A patent/AU2012298918A1/en not_active Abandoned
- 2012-08-22 CA CA 2846435 patent/CA2846435A1/en not_active Abandoned
-
2015
- 2015-12-28 US US14/980,156 patent/US20160151241A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2013028767A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013028767A1 (en) | 2013-02-28 |
| US20160151241A1 (en) | 2016-06-02 |
| US20130053815A1 (en) | 2013-02-28 |
| ES2590492T3 (en) | 2016-11-22 |
| AU2012298918A1 (en) | 2014-03-13 |
| CA2846435A1 (en) | 2013-02-28 |
| EP2747734B1 (en) | 2016-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20160151241A1 (en) | High recovery vial adaptor | |
| US6453956B2 (en) | Needle safe transfer guard | |
| EP3081204B1 (en) | Medical vial access device with pressure equalization and closed drug transfer system | |
| FI81499B (en) | SAEKERHETSANORDNING FOER ANSLUTNING AV EN SPRUTA TILL MYNNINGEN AV EN FLASKA INNEHAOLLANDE ETT LAEKEMEDEL, ELLER TILL ETT ROER I OCH FOER UTTOEMNING AV LAEKEMEDLET FRAON SPRUTAN. | |
| US9333288B2 (en) | Attachable plunger rod and associated packaging | |
| EP2086851B1 (en) | Closure and dispensing system | |
| NO314245B1 (en) | Medical valve with fluid escape room | |
| US11612692B1 (en) | Method and apparatus to reduce the deadspace in syringes and small-bore devices | |
| CA3059809A1 (en) | Method and apparatus for filling syringes with retractable needle | |
| AU2007321704B2 (en) | Closure and dispensing system | |
| HK1179194B (en) | Connector for containers containing medical agents | |
| HK1179194A1 (en) | Connector for containers containing medical agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140307 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20160107 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 807232 Country of ref document: AT Kind code of ref document: T Effective date: 20160715 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602012019762 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20160622 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160922 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 807232 Country of ref document: AT Kind code of ref document: T Effective date: 20160622 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2590492 Country of ref document: ES Kind code of ref document: T3 Effective date: 20161122 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160923 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161022 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161024 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602012019762 Country of ref document: DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20170323 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160822 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160822 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20120822 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160622 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20210825 Year of fee payment: 10 Ref country code: IT Payment date: 20210820 Year of fee payment: 10 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20210827 Year of fee payment: 10 Ref country code: ES Payment date: 20210901 Year of fee payment: 10 Ref country code: GB Payment date: 20210827 Year of fee payment: 10 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602012019762 Country of ref document: DE |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220822 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220822 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220831 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230301 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20231002 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220822 Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220823 |